Morphea - Morfea
☆ Fir-riżultati ta' Stiftung Warentest tal-2022 mill-Ġermanja, is-sodisfazzjon tal-konsumatur b'ModelDerm kien biss ftit inqas milli b'konsultazzjonijiet bit-telemediċina mħallsa.
Il-leżjoni ta 'Morfea (Morphea) normalment tidher bħala garża pigmentata atrofika.
References
Scleroderma hija marda rari li taffettwa t-tessuti konnettivi, li tidher bħala ġilda mwebbsa u kultant taffettwa partijiet oħra tal-ġisem. Hemm żewġ tipi ewlenin: systemic sclerosis , li jinvolvi t-twebbis tal-ġilda u l-organi interni, u localized scleroderma , magħrufa wkoll bħala morphea, li tipikament tibqa’ limitata għall-ġilda u t-tessuti ta’ taħtha, b’kors beninni u li jillimita lilhom infushom. Għalkemm l-iskleroderma lokalizzata mhix komuni u l-kawża tagħha mhix ċara, riċerka reċenti tissuġġerixxi li tista 'taffettwa wkoll l-organi interni u twassal għal diversi kwistjonijiet ta' saħħa. Trattament bikri huwa kruċjali biex jiġu evitati kumplikazzjonijiet, minħabba s-serjetà potenzjali ta' localized scleroderma.
Scleroderma is a rare connective tissue disease that is manifested by cutaneous sclerosis and variable systemic involvement. Two categories of scleroderma are known: systemic sclerosis, characterized by cutaneous sclerosis and visceral involvement, and localized scleroderma or morphea which classically presents benign and self-limited evolution and is confined to the skin and/or underlying tissues. Localized scleroderma is a rare disease of unknown etiology. Recent studies show that the localized form may affect internal organs and have variable morbidity. Treatment should be started very early, before complications occur due to the high morbidity of localized scleroderma.
Scleroderma is a rare connective tissue disease that is manifested by cutaneous sclerosis and variable systemic involvement. Two categories of scleroderma are known: systemic sclerosis, characterized by cutaneous sclerosis and visceral involvement, and localized scleroderma or morphea which classically presents benign and self-limited evolution and is confined to the skin and/or underlying tissues. Localized scleroderma is a rare disease of unknown etiology. Recent studies show that the localized form may affect internal organs and have variable morbidity. Treatment should be started very early, before complications occur due to the high morbidity of localized scleroderma.
Morphea , magħrufa wkoll bħala skleroderma lokalizzata, hija marda awtoimmuni rari li taffettwa t-tessut konnettiv. Jista’ jidher b’modi differenti, u mhux komuni ħafna, b’madwar 0. 4 - 2. 7 każi għal kull 100,000 ruħ kull sena. Morphea spiss jidher fi tfal bejn 2 u 14-il sena, u għandu t-tendenza li jaffettwa l-bniet aktar ta 'spiss mis-subien.
Morphea (localized scleroderma) is a rare autoimmune connective tissue disease with variable clinical presentations, with an annual incidence of 0.4-2.7 cases per 100,000. Morphea occurs most frequently in children aged 2-14 years, and the disease exhibits a female predominance.
Morphea (localized scleroderma) is a rare autoimmune connective tissue disease with variable clinical presentations, with an annual incidence of 0.4-2.7 cases per 100,000. Morphea occurs most frequently in children aged 2-14 years, and the disease exhibits a female predominance.
Morphea hija marda rari ħafna. Minħabba l-kompożizzjoni tar-ritratt, l-algoritmu jista’ jkun żbaljat b’ morfea (morphea) .